Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 10.75
0.186 %
$ 979 M
Market Cap
-7.62
P/E
MYGN - LONG-TERM DEBT
Long-term Debt MYGN - Myriad Genetics, Inc.
136 M
LAST VALUE
30.91%
2 YEAR CAGR
-10.26%
5 YEAR CAGR
0.00%
10 YEAR CAGR